Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels
- 17 August 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 188 (2), 228-235
- https://doi.org/10.1007/s00213-006-0450-z
Abstract
Converging evidences from animal and human studies suggest that addiction is associated with dopaminergic dysfunction in brain reward circuits. So far, it is unclear what aspects of addictive behaviors are related to a dopaminergic dysfunction. We hypothesize that a decrease in dopaminergic activity impairs emotion-based decision-making. To demonstrate this hypothesis, we investigated the effects of a decrease in dopaminergic activity on the performance of an emotion-based decision-making task, the Iowa gambling task (IGT), in 11 healthy human subjects. We used a double-blind, placebo-controlled, within-subject design to examine the effect of a mixture containing the branched-chain amino acids (BCAA) valine, isoleucine and leucine on prolactin, IGT performance, perceptual competency and visual aspects of visuospatial working memory, visual attention and working memory, and verbal memory. The expectancy-valence model was used to determine the relative contributions of distinct IGT components (attention to past outcomes, relative weight of wins and losses, and choice strategies) in the decision-making process. Compared to placebo, the BCAA mixture increased prolactin levels and impaired IGT performance. BCAA administration interfered with a particular component process of decision-making related to attention to more recent events as compared to more distant events. There were no differences between placebo and BCAA conditions for other aspects of cognition. Our results suggest a direct link between a reduced dopaminergic activity and poor emotion-based decision-making characterized by shortsightedness, and thus difficulties resisting short-term reward, despite long-term negative consequences. These findings have implications for behavioral and pharmacological interventions targeting impaired emotion-based decision-making in addictive disorders.Keywords
This publication has 49 references indexed in Scilit:
- Chemistry of the mind: Neurochemical modulation of prefrontal cortical functionJournal of Comparative Neurology, 2005
- Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspectiveNature Neuroscience, 2005
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Long-term heavy marijuana users make costly decisions on a gambling taskDrug and Alcohol Dependence, 2004
- Deciding Advantageously Before Knowing the Advantageous StrategyScience, 1997
- Functional and Anatomical Aspects of Prefrontal Pathology in SchizophreniaSchizophrenia Bulletin, 1997
- Insensitivity to future consequences following damage to human prefrontal cortexCognition, 1994
- Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosisJournal of Hepatology, 1987
- Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the ratBehavioral and Neural Biology, 1985
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960